AngioDynamics (ANGO) Reports Q1 EPS of $0.17

AngioDynamics (NASDAQ: ANGO) reported Q1 EPS of $0.17, versus $0.11 reported last year. Revenue for the quarter came in at $88.1 million, versus $83.8 million reported last year.

The Company announced its FY2017 guidance will remain unchanged, with net sales guidance of $355 million to $360 million and adjusted EPS of $0.62 to $0.65. The Company reiterated its FY2017 free cash flow guidance of greater than $30 million.

For earnings history and earnings-related data on AngioDynamics (ANGO) click here.

You May Also Be Interested In

• BayCom Corp (BCML) Misses Q1 EPS by 4c
• Hilltop Holdings (HTH) Tops Q1 EPS by 17c
• Five Point Holdings, LLC (FPH) Reports Q1 EPS of $0.03